Read more
This book presents a systematic overview of the most relevant nanomaterials and their respective intrinsic properties that have been highly explored by the scientific community and pharmaceutical companies in several different modalities for cancer therapy and bioimaging. The chapters explore the synergistic effects provided by the different nanostructured materials and highlight the main in vitro and in vivo therapeutic achievements on cancer. This work also provides relevant discussion about the recent progresses and future challenges that nanotechnology faces on the conception of more efficient nanoformulations against primary tumors, circulating cancer cells and metastases.
List of contents
Liposomes.- Gold nanoparticles.- Quantum Dots.- Fullerenes.- Polymeric nanoparticles.- Silica nanoparticles.- Micelles.- Magnetic nanoparticles.- Dendrimers.- Protein-based nanoparticles.- Carbon Nanotubes.
About the author
Gil Gonçalves is a Marie Skłodowska-Curie research fellow working at the Institute of Materials Science of Barcelona- Spanish National Research Council (ICMAB-CSIC) on the development of ultra-sensitive nanotherapeutic anticancer agents for neutron capture therapy.
Gerard Tobias leads the research line on “Nanoengineering of Carbon and Inorganic Materials” at the Institute of Materials Science of Barcelona (ICMAB). His research interests focus on the design and development of both carbon and inorganic based functional nanomaterials, with special emphasis on nanoenginnering materials for both diagnosis and therapeutic applications.
Summary
This book presents a systematic overview of the most relevant nanomaterials and their respective intrinsic properties that have been highly explored by the scientific community and pharmaceutical companies in several different modalities for cancer therapy and bioimaging. The chapters explore the synergistic effects provided by the different nanostructured materials and highlight the main in vitro and in vivo therapeutic achievements on cancer. This work also provides relevant discussion about the recent progresses and future challenges that nanotechnology faces on the conception of more efficient nanoformulations against primary tumors, circulating cancer cells and metastases.
